<DOC>
	<DOCNO>NCT01661881</DOCNO>
	<brief_summary>Mantle cell lymphoma ( MCL ) curable conventional therapy . This study seek improve upon standard care newly diagnose , untreated MCL patient transplant-eligible use drug already establish active MCL . The combination Rituximab-Bendamustine follow Rituximab-Cytarabine ( RB/RC ) expect maximize pre-ASCT complete response ( CR ) rate compare historical rate approximate 55 % tolerable toxicity .</brief_summary>
	<brief_title>Rituximab/Bendamustine + Rituximab/Cytarabine Mantle Cell Lymphoma</brief_title>
	<detailed_description>This PII single-arm design determine whether regimen look promising study . Primary Objective â€¢ To evaluate efficacy alternate regimen Rituximab-Bendamustine Rituximab-Cytarabine ( RB/RC ) use CR/Cru rate . Secondary Objectives - To assess safety . - To estimate rate complete remission ( CR ) , unconfirmed CR ( CRu ) , partial remission ( PR ) , stable disease ( SD ) progressive disease ( PD ) . - To estimate rate successful stem cell mobilization RB/RC respond patient . - To estimate proportion patient successfully complete regimen proceed autologous stem cell transplantation ( ASCT ) . - To estimate rate neutrophil platelet engraftment ASCT . - To estimate CR/CRu PR rate patient blastoid variant MCL . - To estimate rate minimal residual disease ( MRD ) -negativity treatment completion .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Mantle-Cell</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<mesh_term>Cytarabine</mesh_term>
	<mesh_term>Bendamustine Hydrochloride</mesh_term>
	<criteria>Mandatory pathologic review diagnostic specimen ( ) Brigham Women 's Hospital Massachusetts General Hospital Measurable disease Candidate ASCT Prior antilymphoma therapy Pregnant breastfeeding Hypersensitivity rituximab Uncontrolled intercurrent illness Receiving study agent HIV positive combination antiretroviral therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Newly diagnose</keyword>
</DOC>